Jeff Yass’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Other funds holding VRDN
KCM
Jeff Yass's VRDN Position: Q3 2026 in Review
Jeff Yass reduced its Viridian Therapeutics (VRDN) stake by 81% in Q3 2026, selling an estimated $2.24M and leaving 25,300 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #9655.
Jeff Yass first reported a position in VRDN in Q1 2015 and has held it in 24 quarters since. The position peaked at $5M in Q2 2023. 235 funds tracked by Wall St. Rank hold VRDN as of Q3 2026.
- Jeff Yass held 25,300 shares of Viridian Therapeutics worth $521K as of Q3 2026.
- Jeff Yass sold 104,984 Viridian Therapeutics shares in Q3 2026, an estimated $2.24M.
- Viridian Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9655 holding.
- Jeff Yass first reported a position in Viridian Therapeutics in Q1 2015 and has held it in 24 quarters since.
- Jeff Yass's Viridian Therapeutics position peaked at $5M in Q2 2023.
- 235 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.